Nibib genotyping samples for tracking viral variants - task order 001
Ended Awarded Last action
- Contract number
- 75N92022F00001
- Awardee
-
Aegis Sciences Corporation UEI GJKTQDATP698
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,480,927
Award facts
- Contract value 15% obligated
-
- $2,480,926.68 Current, with exercised options
- $16,697,986.68 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Nashville, TN 37228, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,073,338 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,680,198 | |
| Original award | $1,874,067 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $16.7 million to Aegis Sciences Corporation (doing business as Aegis Analytical Laboratories) on September 28, 2022, for genotyping samples to track viral variants under the Variant Task Force (VTF) program. This firm fixed-price delivery order, with an ultimate completion date of November 15, 2024, represents work to be performed in Nashville, Tennessee. The award carries no set-aside designation and was made directly to Aegis Sciences based on the company's established expertise in genomic sequencing and viral variant analysis developed through its significant involvement in the federal government's COVID-19 response efforts.
Aegis Sciences Corporation holds an extensive portfolio of federal contracts focused on laboratory testing and genomic services, including a $47.97 million National Institutes of Health (NIH) genotyping services Indefinite Delivery/Indefinite Quantity (IDIQ) contract from which this task order likely derives. As a specialized laboratory services provider with capabilities spanning forensic toxicology, clinical diagnostics, and viral genomic surveillance, Aegis has become a critical partner for federal health agencies. The company's demonstrated ability to deliver sophisticated sequencing and variant tracking services at scale has positioned it as a prime contractor for multiple agencies, supporting the government's ongoing need for surveillance and characterization of emerging viral threats.
Quick answers
Who was awarded contract 75N92022F00001?
75N92022F00001 was awarded to Aegis Sciences Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 28, 2022.
How much is contract 75N92022F00001 worth?
The government has obligated $2,480,927 on 75N92022F00001. Its potential value, with all options, is $16,697,987.
Is contract 75N92022F00001 an order under another contract?
Yes. 75N92022F00001 is a delivery order under 75N92022D00016, an indefinite delivery contract.
Was contract 75N92022F00001 competed?
The extent of competition for 75N92022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award